The clinical practice guidelines for Chinese patent medicines （CPM） provide reference for the selection of national drug catalogs， the formulation of prescription collections in medical institutions， and the clinical use of CPM， constituting an important part of traditional Chinese medicine （TCM） guidelines. As a crucial part of Chinese drug supply guarantee system， CPM plays an important role in the treatment， prevention， and healthcare of many disease categories， whereas the application of CPM has problems of misuse and even abuse. To standardize the application of CPM， a research team at Zhejiang Chinese Medical University developed the Reporting Items for Practice Guidelines in Healthcare for Chinese Patent Medicines （RIGHT for CPM） based on the RIGHT checklist framework. The RIGHT for CPM checklist gathers key information from published CPM guidelines， existing TCM reporting checklists， and the RIGHT checklist and its extensions to form an initial pool of reporting items. Seventeen experts from different disciplines were invited to conduct two rounds of Delphi surveys， and the final checklist was reviewed and approved for publication by 18 leading experts in TCM research and guideline reporting from China and abroad. The RIGHT for CPM checklist adds 16 sub-items and revises 2 sub-items on the basis of the RIGHT checklist， highlighting the characteristics of CPM guideline reporting. It considers CPM selection and inclusion criteria， policy access， indications and symptoms， drug combination instructions， drug use in special populations， precautions， and recommendations of Western medical physicians， among others. This can further improve the quality and transparency of CPM guideline reporting， promote standardized reporting of CPM guidelines， and facilitate the rational clinical use of CPM. This article interprets the development process of the RIGHT for CPM checklist and the items that highlight the characteristics of CPM guidelines， with a view to promoting the application of the RIGHT for CPM checklist.

[Objective]To explore data on traditional Chinese medicine formulas for the treatment of rheumatoid arthritis(RA),analyze medication patterns and provide ideas for the clinical staging treatment of RA.[Methods]Using the China Patent Publication Platform of the State Intellectual Property Office,the patent data of traditional Chinese medicine compounds for RA published from the establishment date of the database to November 2023 were systematically collected,and the frequency of drug application,nature and taste,and efficacy of the included traditional Chinese medicine formulas were analyzed.Correlation analysis,cluster analysis and latent structure analysis were used to explore the core prescriptions of traditional Chinese medicine in the treatment of different stages of RA.[Results]Two hundred and ninety-nine traditional Chinese medicine formulas were included,including 537 traditional Chinese medicines,with a total frequency of 3 739 times.The nature and flavor of the medicines are primarily categorized as warm,neutral,and cold.The channel tropism of the medicines is generally classified into the liver,spleen,kidney,and heart meridians.High-frequency traditional Chinese medicine can be classified into six primary categories and nine secondary subcategories.The high-frequency drug combinations used in association analysis included"Huangqi → Guizhi"and"Ruxiang → Myrrh".The cluster analysis of 58 high-frequency traditional Chinese medicines with frequency≥20 times was carried out,and the results showed that 6 clusters were formed.Among them,wind and dampness obstruction and deficiency of Qi and blood belonged to the pre-RA state,damp-heat obstruction belonged to the acute phase,cold dampness obstruction belonged to the chronic phase,phlegm stasis obstruction and liver and kidney deficiency belonged to the remission phase.[Conclusion]Traditional Chinese medicine formulas therapy for RA often starts from the three major causes of deficiency,evil and blood stasis,by using drugs that dispel wind and dampness,promote blood circulation and remove blood stasis,and nourish deficiency.It follows the principle of"treating the same disease differently"and emphasizes staged treatment,Which providing a certain reference for clinical treatment.

[Objective]To explore data on traditional Chinese medicine formulas for the treatment of rheumatoid arthritis(RA),analyze medication patterns and provide ideas for the clinical staging treatment of RA.[Methods]Using the China Patent Publication Platform of the State Intellectual Property Office,the patent data of traditional Chinese medicine compounds for RA published from the establishment date of the database to November 2023 were systematically collected,and the frequency of drug application,nature and taste,and efficacy of the included traditional Chinese medicine formulas were analyzed.Correlation analysis,cluster analysis and latent structure analysis were used to explore the core prescriptions of traditional Chinese medicine in the treatment of different stages of RA.[Results]Two hundred and ninety-nine traditional Chinese medicine formulas were included,including 537 traditional Chinese medicines,with a total frequency of 3 739 times.The nature and flavor of the medicines are primarily categorized as warm,neutral,and cold.The channel tropism of the medicines is generally classified into the liver,spleen,kidney,and heart meridians.High-frequency traditional Chinese medicine can be classified into six primary categories and nine secondary subcategories.The high-frequency drug combinations used in association analysis included"Huangqi → Guizhi"and"Ruxiang → Myrrh".The cluster analysis of 58 high-frequency traditional Chinese medicines with frequency≥20 times was carried out,and the results showed that 6 clusters were formed.Among them,wind and dampness obstruction and deficiency of Qi and blood belonged to the pre-RA state,damp-heat obstruction belonged to the acute phase,cold dampness obstruction belonged to the chronic phase,phlegm stasis obstruction and liver and kidney deficiency belonged to the remission phase.[Conclusion]Traditional Chinese medicine formulas therapy for RA often starts from the three major causes of deficiency,evil and blood stasis,by using drugs that dispel wind and dampness,promote blood circulation and remove blood stasis,and nourish deficiency.It follows the principle of"treating the same disease differently"and emphasizes staged treatment,Which providing a certain reference for clinical treatment.

[Objective]To explore the therapeutic characteristics,technical points and disease spectrum distribution of clinical studies on five-tone therapy,and to provide a reference for the scientific design and implementation of clinical trials on five-tone therapy.[Methods]Retrieve randomized controlled trial(RCT)literature on five-tone therapy from 9 major databases including China National Knowledge Infrastructure(CNKI),VIP,Wanfang Data,China Biology Medicine disc(CBMdisc),PubMed,Embase,Web of Science,Cochrane Library,and Clinical Trails.Extract information such as literature titles,first authors,symptoms,and intervention measures.Use bibliometric methods to analyze the sample size,intervention methods,treatment frequency,treatment environment,control methods,and symptom spectrum of the included studies.[Results]The sample size of the inclusion of 491 articles was mostly focused on 60～100 patients(60.08%),and five-tone therapy was often used in combination with auricular acupressure,traditional Chinese medicine and acupuncture.Treatment frequency<1 session per day,treatment duration<30 min/session and treatment duration>28 days were the main treatment characteristics.Control measures can be categorized into four types:Chinese medical treatment,western medical treatment,music therapy and blank control,with western medical treatment being used most frequently(446 times).Totally 314 articles(63.95%)reported specific varicosities,of which the Jue tone was the highest,for a total of 108 times.Music therapy involved a total of 66 conditions,which were distributed among 17 disease systems,and the top three most frequent appropriate disease systems were mental and behavioral disorders(112 articles),neurological disorders(76 articles),and oncological disorders(71 articles).[Conclusion]The five-tone therapy has a wide range of indications and great potential for clinical application,but there is still a need to establish standardized standards in terms of treatment time,course of treatment,and other technical aspects.In the future,it is still necessary to design and implement more scientific experimental plans to promote the rational application and promotion of five-tone therapy.

Objective To observe the effect of Bushen Gutai mixture on uterine blood supply of rat model of abortion induced by hydroxyurea tablets combined with mifepristone through PKA-CREB signal pathway and its mechanism of calming fetus.Methods 60 pregnant rats of SPF grade SD rats were prepared by closing cages at 2∶1.According to the order of pregnancy,60 pregnant rats were randomly divided into 6 groups with 10 rats in each group:Bushen Gutai mixture group(low,middle and high dose),normal pregnancy group,model group and Di qu progesterone group.On the 1st to 9th day of pregnancy,except the normal group,the pregnant rats in each group were gavaged with hydroxyurea tablets at 5∶00 pm every day(450 mg·kg-1),and at 10∶00 am on the 10th day of pregnancy.Mifepristone tablets were given by intragastric administration(4.0 mg·kg-1).At 9∶00 am every day from the 1st to 9th day of pregnancy,Bushen Gutai mixture was given to the low,middle and high dose groups(0.5,1.0,2.0 g·kg-1),didrone group(3.02 mg·kg-1),model group and normal pregnancy group with 0.9%normal saline.24 hours after the last administration of pentobarbital sodium(50 mg kg-1),all pregnant rats were killed by intraperitoneal injection of pentobarbital sodium,and the uterine decidual tissue of pregnant rats was bluntly isolated in sterile environment.Hematoxylin-eosin(HE)staining was used to observe the lumen diameter and wall thickness of spiral artery in uterine decidual tissue.Immunohistochemical staining(IHC)was used to detect the expression of vascular endothelial growth factor(VEGF)in decidual tissues.Western blot was used to detect the protein expression of phosphorylated protein kinase A,protein kinase A,phosphorylated cyclic adenosine monophosphate response element binding protein,Cyclic Adenosine monophosphate response element binding protein and aquaporin 5 in the decidua of pregnant rats.The apoptosis of decidual cells was detected by in situ end labeling(TUNEL)of DNA fragmentation.Results Compared with the model group,the wall thickness of spiral artery was higher than that in other groups(P<0.05),the lumen diameter was lower than that in other groups(P<0.05)and the expression of VEGF protein was lower than that of other groups(P<0.01).Compared with the model group,the apoptosis level of decidual cells in uterine decidua of abortive rats in high,middle and low dose groups of Bushen Gutai mixture and diqu progesterone group decreased in varying degrees.Bushen Gutai mixture can up-regulate the levels of p-PKA/PKA and p-CREB/CREB in uterine decidua(P<0.01)and promote the expression of AQP5 protein in uterine decidua of abortion rats(P<0.01).Conclusion Bushen Gutai mixture can improve uterine blood supply of aborted rats by activating PKA and CREB phosphorylation,up-regulating AQP5 expression,promoting physiological recasting of spiral artery and high expression of Vascular endothelial growth factor.